Trulicity (dulaglutide) — Pricing, Dosing, and What to Know

FDA status

FDA-approved 2014

List price

$987/month

Schedule

Once weekly

Form

Subcutaneous injection (prefilled pen)

Quick facts

Generic name	dulaglutide
Brand manufacturer	Eli Lilly
FDA indication	Type 2 diabetes
FDA approval year	2014
Form	Subcutaneous injection (prefilled pen)
Schedule	Once weekly
List price (cash)	$987/month

Available doses

0.75 mg
1.5 mg
3 mg
4.5 mg

What it's used for

Type 2 diabetes (FDA-approved)
Cardiovascular risk reduction (FDA-approved subset)

How Trulicity compares

For drug-class comparisons, see our medication-comparison hub:

Semaglutide vs Tirzepatide Ozempic vs Wegovy Mounjaro vs Zepbound Wegovy vs Zepbound Compounded vs Brand

Insurance coverage

Coverage varies significantly by carrier and employer plan. See our insurance hub for plan-specific guidance:

UnitedHealthcare Anthem BCBS Aetna Cigna Medicare Part D TRICARE

Frequently asked questions

What is Trulicity?

Trulicity is the brand name for dulaglutide, manufactured by Eli Lilly. Trulicity is once-weekly dulaglutide for Type 2 diabetes. Mid-tier weight-loss effect compared to semaglutide and tirzepatide.

How much does Trulicity cost?

Trulicity list price is approximately $987/month. Insurance may cover it with prior authorization for FDA-approved indications.

Is Trulicity FDA-approved?

FDA-approved 2014. Indication: Type 2 diabetes.

What are the dosing steps for Trulicity?

Doses available: 0.75 mg, 1.5 mg, 3 mg, 4.5 mg. Schedule: Once weekly. Always follow your prescribing clinician's titration plan.

What's the difference between Trulicity and other GLP-1s?

See our medication comparisons hub for head-to-head pages on Wegovy vs Zepbound, Ozempic vs Wegovy, and semaglutide vs tirzepatide.

Note: This page is an editorial overview, not medical advice. Always consult a licensed clinician about whether Trulicity is appropriate for you.